TRANEXAMIC Acid Nardia 500 mg/5 ml sol inj

7680705810017 CH-70581 B02AA02 06.06.0.

Active substances:

Acidum tranexamicum

No images available

Details

Product number
7058101
CPT
-
Packaging group
5
Unit
Ampulle(n)
Composition
acidum tranexamicum 500.0 mg, acidum hydrochloridum q.s. ad pH, aqua ad iniectabile q.s. ad solutionem pro 5 ml.

Articles (1)

Tranexamic Acid Nardia 500 mg/5 ml, soluzione iniettabile
soluzione
5
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
01/04/2026
Professional SmPC
Français
01/04/2026
Professional SmPC
Italien
01/04/2026

Detailed composition

Substance Quantity Type Category
acidum tranexamicum
500.0 MG Substance Wirkstoff (Principe actif)
acidum hydrochloridum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Authorization holder

Nardia Pharmaceuticals SA

6855 Stabio

Authorization information

Swissmedic authorization number
70581
Drug name
Tranexamic Acid Nardia, soluzione iniettabile
Galenic form
LSINJ
ATC Code
B02AA02
Authorization status
Z
Dispensation category
B
First authorization
19/02/2026
Authorization expiration date
18/02/2031
IT number
06.06.0.
Domain
Human medicine
Field of application
Antifibrinolytikum, Haemostatikum

Packaging details

Description (FR)
TRANEXAMIC Acid Nardia 500 mg/5 ml sol inj
Description (DE)
TRANEXAMIC Acid Nardia 500 mg/5 ml Inj Lös
Market launch
01/06/2026
Narcotic (BTM)
No

Available generics

Tranexamic OrPha, Filmtabletten
GTIN: 7680700090018
CHF 26.90
View
Buy us a coffee Explore the data